fibrinogen has been researched along with Ph 1 Chromosome in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cortelezzi, A; Fracchiolla, NS; Sciumè, M | 1 |
Duner, E; Fabris, F; Lombardi, AM; Randi, ML; Ruzzon, E; Scandellari, R; Scapin, M; Tezza, F | 1 |
Andreeff, M; Berman, E; Filippa, D; Gansbacher, B; Gee, T; Kempin, S; Little, C; Michaeli, J; Sarris, AH; Straus, D | 1 |
3 other study(ies) available for fibrinogen and Ph 1 Chromosome
Article | Year |
---|---|
Severe hypofibrinogenemia associated with imatinib and prednisone therapy in Philadelphia chromosome-positive acute lymphoblastic leukemia.
Topics: Adult; Afibrinogenemia; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Fibrinogen; Humans; Imatinib Mesylate; Incidence; Male; Middle Aged; Philadelphia Chromosome; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Retrospective Studies; Severity of Illness Index; Treatment Outcome; Young Adult | 2018 |
Haemostatic proteins gene polymorphisms in patients with unusual vein thrombosis and Ph-myeloproliferative disorders.
Topics: Adult; Case-Control Studies; DNA Mutational Analysis; Factor XII; Female; Fibrinogen; Hemostasis; Humans; Integrin beta3; Janus Kinase 2; Male; Philadelphia Chromosome; Polycythemia Vera; Polymorphism, Genetic; Risk Assessment; Risk Factors; Thrombocythemia, Essential; Venous Thrombosis | 2007 |
High incidence of disseminated intravascular coagulation during remission induction of adult patients with acute lymphoblastic leukemia.
Topics: Adult; Disseminated Intravascular Coagulation; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Philadelphia Chromosome; Platelet Count; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prothrombin Time; Remission Induction | 1992 |